Publications

Detailed Information

Apolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxin

DC Field Value Language
dc.contributor.authorCho, Nam-Hyuk-
dc.contributor.authorSeong, Seung-Yong-
dc.date.accessioned2012-06-11T02:26:57Z-
dc.date.available2012-06-11T02:26:57Z-
dc.date.issued2009-09-
dc.identifier.citationIMMUNOLOGY; Vol.128 1; e479-e486ko_KR
dc.identifier.issn0019-2805-
dc.identifier.urihttps://hdl.handle.net/10371/76946-
dc.description.abstractWe suggested earlier that the hydrophobic portions (Hyppos) of molecules, which are normally embedded in the membranes of cells or the core of molecular structures so as to be separated from the aqueous environment, might serve as evolutionarily ancient alarm signals of injury or stress to initiate innate immune responses when they are exposed on the surface. Under normal physiological conditions, the Hyppos released from endogenous or exogenous sources might be handled by `Hyppo-quenchers`in vivo to maintain the tissue homeostasis and immune modulation. To test this idea, we selected apolipoproteins, which have been known to transport blood lipids and play a role in a number of pathological inflammatory conditions. We examined their role as Hyppo-quenchers in early immune responses and found that apolipoproteins showed significant inhibition of the nuclear factor-kappa B-dependent gene expression in recombinant Chinese hamster ovary (CHO) cells and dendritic cells stimulated by necrotic cells or bacterial endotoxin. In addition, our results indicate that apolipoproteins could dramatically abrogate complement fixation on the surface of necrotic cells. These findings suggest that apolipoproteins, besides having known functions in lipid metabolism, also have a role in preventing the initiation of innate immunity, potentially through neutralizing Hyppos from injured cells or exogenous endotoxin.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELL PUBLISHING, INCko_KR
dc.subjectapolipoproteinsko_KR
dc.subjectnecrotic cellko_KR
dc.subjectinnate immunityko_KR
dc.subjectcomplementko_KR
dc.subjectendotoxinko_KR
dc.titleApolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxinko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor조남혁-
dc.contributor.AlternativeAuthor성승용-
dc.identifier.doi10.1111/j.1365-2567.2008.03002.x-
dc.citation.journaltitleIMMUNOLOGY-
dc.description.citedreferenceJiao YL, 2008, CYTOKINE, V43, P83, DOI 10.1016/j.cyto.2008.04.002-
dc.description.citedreferenceChiesa G, 2008, CURR OPIN CARDIOL, V23, P379-
dc.description.citedreferenceXu W, 2008, J IMMUNOL, V180, P7613-
dc.description.citedreferenceTanimoto N, 2007, BIOCHEM BIOPH RES CO, V361, P533, DOI 10.1016/j.bbrc.2007.07.060-
dc.description.citedreferenceWilliams KJ, 2007, CURR OPIN LIPIDOL, V18, P443-
dc.description.citedreferenceMiyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002-
dc.description.citedreferenceSim RB, 2007, IMMUNOBIOLOGY, V212, P355, DOI 10.1016/j.imbio.2007.04.001-
dc.description.citedreferenceKrysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8-
dc.description.citedreferenceGarber DW, 2006, CURR PHARM BIOTECHNO, V7, P235-
dc.description.citedreferenceYan YJ, 2006, LIFE SCI, V79, P210, DOI 10.1016/j.lfs.2006.02.011-
dc.description.citedreferenceBottcher A, 2006, ARTHRITIS RHEUM, V54, P927, DOI 10.1002/art.21660-
dc.description.citedreferenceGaipl US, 2006, CURR TOP MICROBIOL, V305, P161-
dc.description.citedreferenceSEONG SY, 2006, CURR PROTEOMICS, V3, P129-
dc.description.citedreferenceElward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200-
dc.description.citedreferenceGupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48-
dc.description.citedreferenceLane RM, 2005, J LIPID RES, V46, P949, DOI 10.1194/jlr.M400486-JLR200-
dc.description.citedreferenceBerbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215-
dc.description.citedreferenceTsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127-
dc.description.citedreferenceCiurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045-
dc.description.citedreferenceSeong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372-
dc.description.citedreferenceMa J, 2004, ACTA BIOCH BIOPH SIN, V36, P419-
dc.description.citedreferenceBresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443-
dc.description.citedreferenceMarcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/01.mol.0000064046.68936.f8-
dc.description.citedreferenceCalabresi L, 2003, CIRC RES, V92, P330, DOI 10.1161/01.RES.0000054201.60308.1A-
dc.description.citedreferenceBeg AA, 2002, TRENDS IMMUNOL, V23, P509-
dc.description.citedreferenceFurlaneto CJ, 2002, LIPIDS, V37, P925, DOI 10.1007/s11745-002-0981-4-
dc.description.citedreferenceScaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858-
dc.description.citedreferenceJaneway CA, 2002, ANNU REV IMMUNOL, V20, P197-
dc.description.citedreferenceBURGER D, 2002, AUTOIMMUN REV, V1, P111-
dc.description.citedreferenceMedvedev AE, 2001, J IMMUNOL, V167, P2257-
dc.description.citedreferenceLi M, 2001, J IMMUNOL, V166, P7128-
dc.description.citedreferenceGaipl US, 2001, CELL DEATH DIFFER, V8, P327-
dc.description.citedreferenceGallucci S, 2001, CURR OPIN IMMUNOL, V13, P114-
dc.description.citedreferenceBanchereau J, 2000, ANNU REV IMMUNOL, V18, P767-
dc.description.citedreferenceGallucci S, 1999, NAT MED, V5, P1249-
dc.description.citedreferenceHeine H, 1999, J IMMUNOL, V162, P6971-
dc.description.citedreferenceBERGER D, 1990, FEBS LETT, V277, P33-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share